Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
PfizerPFE |
-$140,000 |
 |
ZomedicaZOM |
$4.1M |
 |
Johnson & JohnsonJNJ |
-$3.66B |
 |
Mind Medicine (MindMed)MNMD |
-$48M |
 |
ModernaMRNA |
-$388B |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Collins Cooper C. | Aug 22, 2024 | Buy | 4,094 | $1.734 | $7,100 |
| Collins Cooper C. | Aug 21, 2024 | Buy | 1,200 | $1.6988 | $2,000 |
| Walker Marlan D | Dec 7, 2023 | Sell | 4,550 | $2.239 | $10,000 |
| Walker Marlan D | Dec 6, 2023 | Sell | 14,500 | $2.3101 | $33,000 |
| Walker Marlan D | Apr 12, 2023 | Sell | 1,170 | $3.6543 | $4,300 |
| Donegan Michael C | Jan 27, 2023 | Sell | 49 | $5.09 | $250 |
| Donegan Michael C | Jan 26, 2023 | Sell | 1,648 | $5.0796 | $8,400 |
| Donegan Michael C | Jan 24, 2023 | Sell | 7 | $5.3101 | $37 |
| Donegan Michael C | Jan 23, 2023 | Sell | 1,302 | $5.3383 | $7,000 |
| Rubric Capital Management LP | Dec 30, 2022 | Sell | 29,000 | $1333 | $39M |
| Rubric Capital Management LP | Dec 9, 2022 | Buy | 14,825 | $6.09 | $90,000 |
| Bernick Brian | Dec 9, 2022 | Sell | 320 | $6.3121 | $2,000 |
| Rubric Capital Management LP | Dec 8, 2022 | Buy | 300 | $5.83 | $1,700 |
| Rubric Capital Management LP | Dec 7, 2022 | Buy | 20,113 | $5.6625 | $110,000 |
| Naughton Gail K | Dec 7, 2022 | Sell | 3,922 | $5.2614 | $21,000 |
| Walker Marlan D | Dec 6, 2022 | Sell | 1,048 | $4.9475 | $5,200 |
| Bernick Brian | Dec 6, 2022 | Sell | 935 | $4.9215 | $4,600 |
| Glickman Mark A | Dec 6, 2022 | Sell | 440 | $4.9215 | $2,200 |
| Donegan Michael C | Dec 6, 2022 | Sell | 910 | $4.775 | $4,300 |
| Rubric Capital Management LP | Oct 28, 2022 | Buy | 7,000 | $1000 | $7M |
What's the latest insider transaction for TherapeuticsMD?
The most recent insider transaction for TherapeuticsMD was conducted by Collins Cooper C., who sold 4,094 shares on August 22, 2024 at a price of $1.73 per share.
Which insider bought the most TXMD stock over the last two years?
Rubric Capital Management LP has bought the most TXMD stock in the last 2 years, with a total value of $7.2M.
Which insider has sold the most TXMD stock over the last two years?
Rubric Capital Management LP has sold the most TXMD stock in the last 2 years, with a total value of $39M.
What is the total value of insider transactions for TherapeuticsMD (TXMD) in the last 2 years?
The total value of insider transactions for TherapeuticsMD in the last 2 years is negative, amounting to -$32M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on TherapeuticsMD's market confidence?
Over the last 2 years, insider transactions for TherapeuticsMD have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
